Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
Shoulder Innovations (SI) has entered into a settlement agreement with Catalyst OrthoScience to resolve all outstanding patent litigation between the companies.
Rhea-AI Summary
Shoulder Innovations (SI) has entered into a settlement agreement with Catalyst OrthoScience to resolve all outstanding patent litigation between the companies.
The settlement terms are confidential. CEO Rob Ball said the resolution provides an agreeable solution to the patent dispute and emphasized that protecting intellectual property is fundamental to supporting the company’s investments in innovation. The company believes the outcome allows it to continue focusing on advancing shoulder arthroplasty and delivering improved outcomes for surgeons and patients.
Positive
- None.
Negative
- None.
Key Terms
shoulder arthroplasty medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. "Protecting our intellectual property is fundamental to ensuring that the investments we make in innovation continue to benefit Shoulder Innovations stakeholders, particularly including surgeons and patients. We believe this outcome enables us to continue to deliver on what matters most – advancing shoulder arthroplasty and delivering the best possible outcomes for patients."
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-announces-settlement-of-patent-litigation-with-catalyst-orthoscience-302872774.html
SOURCE Shoulder Innovations